BeyondSpring (BYSI) Other Working Capital Changes (2020 - 2026)
BeyondSpring (BYSI) posted Other Working Capital Changes of -$500000.0 for Q1 2026, little changed sequentially from -$500000.0 in Q4 2025, and little changed YoY from -$500000.0 in Q1 2025.
BeyondSpring (BYSI) Other Working Capital Changes (2020 - 2026) Analysis & Trends
BeyondSpring has reported Other Working Capital Changes for 5 years, with the latest figure at -$500000.0 in Q1 2026.
- Quarterly Other Working Capital Changes changed 0.0% year-over-year to -$500000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.0 million (changed 0.0% YoY) and the FY2025 annual result came in at -$2.0 million, down 99.9% from the prior year.
- Other Working Capital Changes steadied at -$500000.0 in Q1 2026 per BYSI's latest filing, from -$500000.0 in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $174000.0 in Q2 2024 and troughed at -$101000.0 in Q3 2025.
- A 3-year average of $3666.7 and a median of -$54000.0 in 2024 frame the typical range for Other Working Capital Changes.
- The widest YoY moves for Other Working Capital Changes: up 38.2% in 2025, down 200.0% in 2025.
- Over 3 years, Other Working Capital Changes stood at -$500000.0 in 2024, then changed by 0.0% to -$500000.0 in 2025, then changed by 0.0% to -$500000.0 in 2026.
- According to Business Quant data, Other Working Capital Changes over the past three periods registered -$500000.0, -$500000.0, and -$501000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | BeyondSpring | 30.22 Mn | 30.22 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -500,000.00 |
| Jun 30, 2026 | -500,000.00 |
| Jun 30, 2026 | -500,000.00 |
| Mar 31, 2026 | -500,000.00 |
| Mar 31, 2026 | -500,000.00 |
| Mar 31, 2026 | -500,000.00 |
| Dec 31, 2025 | -500,000.00 |
| Dec 31, 2025 | -500,000.00 |
| Dec 31, 2025 | -500,000.00 |
| Sep 30, 2025 | -501,000.00 |
| Sep 30, 2025 | -501,000.00 |
| Sep 30, 2025 | -501,000.00 |
| Jun 30, 2025 | -500,000.00 |
| Jun 30, 2025 | -500,000.00 |
| Jun 30, 2025 | -500,000.00 |
| Mar 31, 2025 | -500,000.00 |
| Mar 31, 2025 | -500,000.00 |
| Mar 31, 2025 | -500,000.00 |
| Dec 31, 2024 | -500,000.00 |
| Dec 31, 2024 | -500,000.00 |